Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikashi Yoshida

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Chronic myelogenous leukemia]Chikashi Yoshida
Med (New York, N.Y.)|August 10, 2024
Asciminib: the next-generation bullet for first-line treatment of chronic myeloid leukemiaChikashi Yoshida, Tomoiku Takaku
International Journal of Hematology|July 9, 2004
Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant diseaseChikashi Yoshida, Junia V Melo
Internal Medicine (Tokyo, Japan)|April 19, 2011
Diffuse large B-cell lymphoma carrying both t(3 ; 7)(q27 ; p12) and t(8 ; 14)(q24 ; q32)Yukitaka Katsura, Ikuyo Ohta, Chikashi Yoshida, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2014
HIV-associated peripheral T-cell lymphoma with a cytotoxic phenotypeYukitaka Katsura, Ikuyo Ota, Chikashi Yoshida, et al.
Journal of Epidemiology|October 25, 2021
Impact of the Clinical Trials Act on Noncommercial Clinical Research in Japan: An Interrupted Time-series AnalysisIkuyo Tsutsumi, Yusuke Tsutsumi, Chikashi Yoshida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 2010
[Prediction of treatment efficacy by the M-protein reduction rate after the first cycle of VAD therapy for multiple myeloma]Yuriko Momma, Atsushi Shinagawa, Takayuki Katsura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 25, 2011
[Progressive multifocal leukoencephalopathy after rituximab therapy in a patient with mantle cell lymphoma]Ikuyo Ota, Yukitaka Katsura, Chikashi Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 14, 2019
[Successful Treatment of T-Cell Prolymphocytic Leukemia with Alemtuzumab]Daisuke Ueki, Chikashi Yoshida, Ikuyo Tsutsumi Oota, et al.
International Journal of Clinical Oncology|July 14, 2019
Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort studyIkuyo Tsutsumi, Susumu Kunisawa, Chikashi Yoshida, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Chronic myelogenous leukemia]Chikashi Yoshida
Med (New York, N.Y.)|August 10, 2024
Asciminib: the next-generation bullet for first-line treatment of chronic myeloid leukemiaChikashi Yoshida, Tomoiku Takaku
International Journal of Hematology|July 9, 2004
Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant diseaseChikashi Yoshida, Junia V Melo
Internal Medicine (Tokyo, Japan)|April 19, 2011
Diffuse large B-cell lymphoma carrying both t(3 ; 7)(q27 ; p12) and t(8 ; 14)(q24 ; q32)Yukitaka Katsura, Ikuyo Ohta, Chikashi Yoshida, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2014
HIV-associated peripheral T-cell lymphoma with a cytotoxic phenotypeYukitaka Katsura, Ikuyo Ota, Chikashi Yoshida, et al.
Journal of Epidemiology|October 25, 2021
Impact of the Clinical Trials Act on Noncommercial Clinical Research in Japan: An Interrupted Time-series AnalysisIkuyo Tsutsumi, Yusuke Tsutsumi, Chikashi Yoshida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 2010
[Prediction of treatment efficacy by the M-protein reduction rate after the first cycle of VAD therapy for multiple myeloma]Yuriko Momma, Atsushi Shinagawa, Takayuki Katsura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 25, 2011
[Progressive multifocal leukoencephalopathy after rituximab therapy in a patient with mantle cell lymphoma]Ikuyo Ota, Yukitaka Katsura, Chikashi Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 14, 2019
[Successful Treatment of T-Cell Prolymphocytic Leukemia with Alemtuzumab]Daisuke Ueki, Chikashi Yoshida, Ikuyo Tsutsumi Oota, et al.
International Journal of Clinical Oncology|July 14, 2019
Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort studyIkuyo Tsutsumi, Susumu Kunisawa, Chikashi Yoshida, et al.
Pageof 6